Health Care & Life Sciences » Pharmaceuticals | AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.03
Market Cap
AUD287.06 M
Shares Outstanding
97.31 M
Public Float
-
AFT Pharmaceuticals Ltd.
Stock Exchange New Zealand Stock Exchange
EPS
NZD0.03
Market Cap
NZD299.71 M
Shares Outstanding
97.31 M
Public Float
10.3 M

Profile

Address
Nielsen House
Auckland AU 0622
New Zealand
Employees -
Website http://www.aftpharm.com
Updated 07/08/2019
AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. Its feature brands include Crystaderm, Maxigesic, Coco-Scalp, Maxiclear, Eyecare Hub, and Allergy Hub. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World.

Financials

View All

Nate Hukill
Non-Executive Director
Douglas John Wilson
Independent Director